Q9987 HCPCS Level II code: Pathogen(s) test for platelets
CMS terminated Q9987: its last date of service was Dec 31, 2017. It stays here for looking up older claims; newer services need a current code.
Official description
Q9987Pathogen(s) test for platelets
Short description: Pathogen test for platelets
HCPCS · United States
Medicare details
The indicators CMS publishes with Q9987 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Other carrier priced
- Type of service
- Diagnostic laboratory
- BETOS category
- Lab tests - other (Non-Medicare fee schedule)
- Cross-reference
- See P9100
- Added
- Jul 1, 2017
- Terminated after
- Dec 31, 2017
Where Q9987 sits
- 1Q codesTemporary codes
- 2Terminated Q9987Pathogen(s) test for platelets
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code Q9987 still valid?
No. CMS terminated Q9987; its last date of service was Dec 31, 2017. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover Q9987?
CMS lists Q9987’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q9987
All Q codesQ9981Rolapitant, oral, 1 mgQ9982Flutemetamol f18, diagnostic, per study dose, up to 5 millicuriesQ9983Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuriesQ9984Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mgQ9985Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mgQ9986Injection, hydroxyprogesterone caproate, (makena), 10 mgQ9988Platelets, pheresis, pathogen-reduced, each unitQ9989Ustekinumab, for intravenous injection, 1 mgQ9991Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mgQ9992Injection, buprenorphine extended-release (sublocade), greater than 100 mgQ9993Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mgQ9994In-line cartridge containing digestive enzyme(s) for enteral feeding, each